UTHR vs. COST
Compare and contrast key facts about United Therapeutics Corporation (UTHR) and Costco Wholesale Corporation (COST).
Performance
UTHR vs. COST - Performance Comparison
Loading graphics...
UTHR vs. COST - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
UTHR United Therapeutics Corporation | 17.04% | 38.09% | 60.46% | -20.93% | 28.70% | 42.35% | 72.33% | -19.12% | -26.39% | 3.15% |
COST Costco Wholesale Corporation | 15.72% | -5.39% | 39.62% | 49.00% | -19.05% | 51.82% | 32.67% | 45.70% | 10.60% | 22.37% |
Fundamentals
UTHR:
$27.90
COST:
$25.63
UTHR:
20.44
COST:
38.88
UTHR:
0.67
COST:
3.04
UTHR:
8.57
COST:
1.16
UTHR:
$3.18B
COST:
$286.27B
UTHR:
$2.80B
COST:
$19.33B
UTHR:
$1.82B
COST:
$12.73B
Returns By Period
In the year-to-date period, UTHR achieves a 17.04% return, which is significantly higher than COST's 15.72% return. Over the past 10 years, UTHR has underperformed COST with an annualized return of 17.58%, while COST has yielded a comparatively higher 22.28% annualized return.
UTHR
- 1D
- -3.83%
- 1M
- 10.99%
- YTD
- 17.04%
- 6M
- 30.15%
- 1Y
- 85.83%
- 3Y*
- 36.55%
- 5Y*
- 24.28%
- 10Y*
- 17.58%
COST
- 1D
- 0.01%
- 1M
- -0.62%
- YTD
- 15.72%
- 6M
- 8.94%
- 1Y
- 4.99%
- 3Y*
- 27.83%
- 5Y*
- 24.29%
- 10Y*
- 22.28%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
UTHR vs. COST — Risk / Return Rank
UTHR
COST
UTHR vs. COST - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for United Therapeutics Corporation (UTHR) and Costco Wholesale Corporation (COST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| UTHR | COST | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.71 | 0.25 | +1.46 |
Sortino ratioReturn per unit of downside risk | 3.11 | 0.50 | +2.61 |
Omega ratioGain probability vs. loss probability | 1.43 | 1.06 | +0.37 |
Calmar ratioReturn relative to maximum drawdown | 5.20 | 0.31 | +4.89 |
Martin ratioReturn relative to average drawdown | 13.21 | 0.61 | +12.60 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| UTHR | COST | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.71 | 0.25 | +1.46 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.69 | 1.08 | -0.39 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.50 | 1.02 | -0.52 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.39 | 0.59 | -0.20 |
Correlation
The correlation between UTHR and COST is 0.19, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
UTHR vs. COST - Dividend Comparison
UTHR has not paid dividends to shareholders, while COST's dividend yield for the trailing twelve months is around 0.52%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
UTHR United Therapeutics Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
COST Costco Wholesale Corporation | 0.52% | 0.59% | 0.49% | 2.87% | 0.76% | 0.54% | 3.38% | 0.86% | 1.08% | 4.81% | 1.09% | 4.06% |
Drawdowns
UTHR vs. COST - Drawdown Comparison
The maximum UTHR drawdown since its inception was -93.18%, which is greater than COST's maximum drawdown of -53.39%. Use the drawdown chart below to compare losses from any high point for UTHR and COST.
Loading graphics...
Drawdown Indicators
| UTHR | COST | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -93.18% | -53.39% | -39.79% |
Max Drawdown (1Y)Largest decline over 1 year | -16.35% | -19.35% | +3.00% |
Max Drawdown (5Y)Largest decline over 5 years | -33.00% | -31.40% | -1.60% |
Max Drawdown (10Y)Largest decline over 10 years | -55.56% | -31.40% | -24.16% |
Current DrawdownCurrent decline from peak | -3.83% | -6.95% | +3.12% |
Average DrawdownAverage peak-to-trough decline | -35.52% | -13.40% | -22.12% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.43% | 9.67% | -3.24% |
Volatility
UTHR vs. COST - Volatility Comparison
United Therapeutics Corporation (UTHR) has a higher volatility of 17.27% compared to Costco Wholesale Corporation (COST) at 4.38%. This indicates that UTHR's price experiences larger fluctuations and is considered to be riskier than COST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| UTHR | COST | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 17.27% | 4.38% | +12.89% |
Volatility (6M)Calculated over the trailing 6-month period | 27.12% | 13.33% | +13.79% |
Volatility (1Y)Calculated over the trailing 1-year period | 50.58% | 20.08% | +30.50% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 35.31% | 22.51% | +12.80% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 35.33% | 21.90% | +13.43% |
Financials
UTHR vs. COST - Financials Comparison
This section allows you to compare key financial metrics between United Therapeutics Corporation and Costco Wholesale Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
UTHR vs. COST - Profitability Comparison
UTHR - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, United Therapeutics Corporation reported a gross profit of 686.80M and revenue of 790.20M. Therefore, the gross margin over that period was 86.9%.
COST - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Costco Wholesale Corporation reported a gross profit of -8.80B and revenue of 69.60B. Therefore, the gross margin over that period was -12.6%.
UTHR - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, United Therapeutics Corporation reported an operating income of 356.70M and revenue of 790.20M, resulting in an operating margin of 45.1%.
COST - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Costco Wholesale Corporation reported an operating income of 2.61B and revenue of 69.60B, resulting in an operating margin of 3.7%.
UTHR - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, United Therapeutics Corporation reported a net income of 364.30M and revenue of 790.20M, resulting in a net margin of 46.1%.
COST - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Costco Wholesale Corporation reported a net income of 2.04B and revenue of 69.60B, resulting in a net margin of 2.9%.